| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 116.6 | 128.3 |
| Gross profit | 85.0 | 94.0 |
| Profit before tax | 5.4 | 9.7 |
| Net income | 1.9 | 5.3 |
| EPS (diluted, $ a share) | $0.11 | $0.30 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -64.6% |
|---|---|
| Revenue, year on year | -9.1% |
| Gross margin | 72.9% |
| Operating margin | 4.5% |
10-Q filed with the SEC, NASDAQ: NATR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Natures Sunshine Products Inc: key numbers
- Share price
- $10.33Close, Nov 17
- Market cap
- $179M
- Shares outstanding
- 17.33MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Natures Sunshine Products Inc
All →Natures Sunshine Products Insider Prescott Group Capital Management L.L.C. Buys $2.83M of Stock
Prescott Group Capital Management L.L.C. bought 289,547 shares of Natures Sunshine Products Inc at $9.55 to $9.95 a share (average $9.77) in 14 transactions, worth $2.83M in total on Nov 5, 2026. Shares held after the trade: 2,236,152 (+0.4%).
- Value
- $2.83M
- Shares
- 289,547
- Average price
- $9.77
- Holding change
- +0.4%
- Trade date
- Nov 5, 2026
Natures Sunshine Products Financial Results
Nature’s Sunshine Products reported third quarter 2026 net sales of $116.6 million, a 9% decrease compared to the prior year, driven by operational disruptions in China and challenges in its Digital business. GAAP net income fell to $1.9 million, or $0.11 per diluted share, down from $5.3 million in the same period last year.
- Term
- Q3 2026
“Our third-quarter results were disappointing and fell short of our expectations. We faced several challenges in our business, particularly in China and in our Digital business.”
Ken Romanzi, CEO of Nature’s Sunshine
“While our third quarter performance was far from our expectations, our confidence in the long-term potential of Nature's Sunshine remains strong.”
Ken Romanzi, CEO of Nature’s Sunshine